Bradley W Blaser

Bradley W Blaser

UNVERIFIED PROFILE

Are you Bradley W Blaser?   Register this Author

Register author
Bradley W Blaser

Bradley W Blaser

Publications by authors named "Bradley W Blaser"

Are you Bradley W Blaser?   Register this Author

24Publications

607Reads

33Profile Views

Quantifying Hematopoietic Stem Cell Clonal Diversity by Selecting Informative Amplicon Barcodes.

Sci Rep 2020 Feb 7;10(1):2153. Epub 2020 Feb 7.

The Ohio State University College of Medicine, Department of Medicine, Division of Hematology, The Ohio State University Comprehensive Cancer Center, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-020-59119-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005852PMC
February 2020

Making HSCs in vitro: don't forget the hemogenic endothelium.

Blood 2018 09 8;132(13):1372-1378. Epub 2018 Aug 8.

Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Harvard Stem Cell Institute, Howard Hughes Medical Institute, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2018-04-784140DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161767PMC
September 2018

CXCR1 remodels the vascular niche to promote hematopoietic stem and progenitor cell engraftment.

J Exp Med 2017 04 28;214(4):1011-1027. Epub 2017 Mar 28.

Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Medical School, Harvard Stem Cell Institute, Stem Cell and Regenerative Biology Department, Harvard University, Boston, MA 02138

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1084/jem.20161616DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379982PMC
April 2017

Generation of Parabiotic Zebrafish Embryos by Surgical Fusion of Developing Blastulae.

J Vis Exp 2016 06 11(112). Epub 2016 Jun 11.

Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School; Division of Hematology, Department of Medicine, Brigham and Women's Hospital; Harvard Stem Cell Institute; Broad Institute of Massachusetts Institute of Technology;

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927786PMC
http://dx.doi.org/10.3791/54168DOI Listing
June 2016

Hyperlipidemia and statin use after allogeneic hematopoietic stem cell transplantation.

Biol Blood Marrow Transplant 2012 Apr 11;18(4):575-83. Epub 2011 Aug 11.

Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2011.08.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805283PMC
April 2012

A novel mouse model for the aggressive variant of NK cell and T cell large granular lymphocyte leukemia.

Leuk Res 2010 Feb 5;34(2):203-9. Epub 2009 Aug 5.

Department of Molecular Virology, Immunology, and Medical Genetics, Department of Internal Medicine, Division of Hematology/Oncology, The Ohio State University College of Medicine, Columbus, OH, United States.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S014521260900343
Publisher Site
http://dx.doi.org/10.1016/j.leukres.2009.06.031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2814907PMC
February 2010

Pharmacologic inhibition of CDK4/6: mechanistic evidence for selective activity or acquired resistance in acute myeloid leukemia.

Blood 2007 Sep 30;110(6):2075-83. Epub 2007 May 30.

Department of Pharmacology, The Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-02-071266DOI Listing
September 2007

Autologous immune strategies to reduce the risk of leukemic relapse: consideration for IL-15.

Best Pract Res Clin Haematol 2006 ;19(2):281-92

The Ohio State University Medical Center, The Ohio State University, 458 A Starling Loving Hall, 320 W 10th Avenue, Columbus, OH 43210-1214, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2005.11.004DOI Listing
July 2006

Tumor growth impedes natural-killer-cell maturation in the bone marrow.

Blood 2006 Jul 23;108(1):246-52. Epub 2006 Mar 23.

Division of Cancer Immunology, Department of Pathology, The Ohio State University Medical Center and Comprehensive Cancer Center, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/content/108/1/246.full.pdf
Web Search
http://www.bloodjournal.org/content/early/2006/03/23/blood-2
Web Search
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2005-11-45
Publisher Site
http://dx.doi.org/10.1182/blood-2005-11-4535DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1895835PMC
July 2006

STAT-1-mediated repression of monocyte interleukin-10 gene expression in vivo.

Eur J Immunol 2006 Mar;36(3):623-30

Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.200535241DOI Listing
March 2006

IL-15 but not IL-2 rapidly induces lethal xenogeneic graft-versus-host disease.

Blood 2005 Oct 23;106(7):2433-5. Epub 2005 Jun 23.

Department of Molecular Virology, Immunology, and Medical Genetics, the Medical Scientist Program, the Integrated Biomedical Science Graduate Program, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2005-04-1597DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1895258PMC
October 2005

Donor-derived IL-15 is critical for acute allogeneic graft-versus-host disease.

Blood 2005 Jan 16;105(2):894-901. Epub 2004 Sep 16.

Division of Human Cancer Genetics, Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2004-05-1687DOI Listing
January 2005

New directions in natural killer cell-based immunotherapy of human cancer.

Expert Opin Biol Ther 2003 Apr;3(2):237-50

Department of Internal Medicine, The Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.3.2.237DOI Listing
April 2003